Skip to main content
    I

    InspireMD Inc (NSPR)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $0.65
    +0.05 (+8.33%)

    Market Cap: $28.07M

    Last updated: Nov 17, 2026 at 4:38 PM ET

    InspireMD Inc (NSPR) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    InspireMD (NSPR) has a market cap of $28.07M and an enterprise value of $10.54M. Its share count is up 16.54% from a year earlier. It holds $17.54M more cash than debt, 62.47% of its market cap.

    Total Valuation

    Enterprise value is 62.47% below the market cap, as cash exceeds debt.

    Market Cap$28.07M
    Enterprise Value$10.54M
    Latest price (Nov 17, 2026)$0.65

    Key Dates

    The next earnings report is expected on Mar 16, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 16, 2027 (expected)
    Last Earnings DateNov 12, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 16.54% in the quarter ended Sep 30, 2026 and grew 33.04% a year over 2 years.

    Shares Outstanding85.62M
    Shares Change (YoY)+16.54%
    Shares Change (QoQ)+16.54%
    Share Count Growth (2Y CAGR)+33.04%

    Valuation Ratios

    Sales and book value multiples are 5.3x and 2.6x. Its year-end P/S ranged from 0.5x to 15.5x from 2019 to 2025.

    P/S Ratio5.3x
    Forward P/S2.9x
    P/B Ratio2.6x

    Valuation history and multiples

    Price Statistics

    The stock is down 69.19% over 52 weeks and trades 4.84% above its 50-day average.

    Beta (1Y)1.45
    52-Week Change-69.19%
    1-Month Change+47.73%
    3-Month Change-28.56%
    6-Month Change-35.00%
    5-Year Change-88.64%
    10-Year Change-100.00%
    Total Return (1Y)-69.19%
    Total Return (3Y CAGR)-39.35%
    Total Return (5Y CAGR)-28.81%
    Max Drawdown (1Y)-79.60%
    Max Drawdown (3Y)-88.15%
    Sharpe Ratio (1Y)-1.46
    Correlation with SPY (1Y)0.26
    50-Day Average$0.62
    200-Day Average$1.01
    52-Week Range$0.43 to $2.17
    RSI (14 Days)52.1
    Average Volume (20 Days)498.82K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.99x current liabilities, and total debt is 0.08x shareholder equity.

    Current Ratio2.99x
    Quick Ratio2.64x
    Debt / Equity0.08x

    Returns and Efficiency

    Return on invested capital is -163.84% over the last 12 months, against a 5-year average of -74.35%.

    Return on Assets (ROA)-105.93%
    Return on Invested Capital (ROIC)-163.84%
    ROE (5Y Average)-75.66%
    ROA (5Y Average)-58.61%
    ROIC (5Y Average)-74.35%
    Inventory Turnover3.24x
    Receivables Turnover4.45x
    Cash Conversion Cycle-8 days

    Scores

    NSPR has an Altman Z-Score of -14.21, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Altman Z-Score-14.21
    Altman Z ZoneDistress
    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Balance Sheet

    Cash and Equivalents$19.25M
    Total Debt$1.71M
    Net Cash$17.54M
    Net Cash Per Share$0.20

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Growth

    Revenue grew 20.19% a year over 3 years.

    Revenue Growth (3Y CAGR)+20.19%
    Revenue Growth (5Y CAGR)+29.29%
    Book Value Per Share Growth (2Y CAGR)-32.06%
    Tangible Book Per Share Growth (2Y CAGR)-32.06%

    Revenue and profit by year

    Dividends and Yields

    NSPR does not pay a dividend. Its free cash flow yield is -79.75%.

    FCF Yield-79.75%
    Shareholder Yield0.00%

    Stock Splits

    The last split was a 1-for-15 reverse split on Apr 27, 2021.

    Last Split DateApr 27, 2021
    Split TypeReverse split
    Split Ratio1:15

    Peer Position

    Against 11 similar companies, NSPR has the 4th highest P/S.

    P/S Ratio5.3x vs 1.3x median
    ROIC-163.84% vs -111.14% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 49.74% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+49.74%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About NSPR

    What is NSPR's market cap?

    InspireMD has a market cap of $28.07M. Its enterprise value, which adds debt and subtracts cash, is $10.54M.

    How many shares of NSPR are outstanding?

    InspireMD has 85.62M shares outstanding. The count is up 16.54% from a year earlier.

    Does NSPR pay a dividend?

    No. InspireMD does not pay a dividend.

    How much debt does NSPR have?

    InspireMD has $1.71M of total debt and $19.25M of cash and equivalents, a net cash position of $17.54M.